848485-43-8

Basic information

• Product Name: Benzoic acid, 3-iodo-4-[(trifluoroacetyl)amino]-, methyl ester
• CAS NO: 848485-43-8
• Molecular Formula: C10H7F3INO3
• Molecular Weight: 373.07
• Mol File: 848485-43-8.mol
• Article Data: 9

Chemical Properties

• CAS DataBase Reference: Benzoic acid, 3-iodo-4-[(trifluoroacetyl)amino]-, methyl ester(CAS DataBase Reference)
• NIST Chemistry Reference: Benzoic acid, 3-iodo-4-[(trifluoroacetyl)amino]-, methyl ester(848485-43-8)
• EPA Substance Registry System: Benzoic acid, 3-iodo-4-[(trifluoroacetyl)amino]-, methyl ester(848485-43-8)

Safety Data

• Hazardous Substances Data: 848485-43-8(Hazardous Substances Data)

Upstream product

• 619-45-4 4-methoxycarbonyl aniline 
• 14452-30-3 3'-iodoacetophenone 
• 407-25-0 trifluoroacetic anhydride 
• 19718-49-1 4-amino-3-iodobenzoic acid methyl ester 

Downstream Products

• 1332828-74-6 bis-(O-toluoyl)-1α-{[2-(N-trifluoroacyl)-5-(carboxymethyl)phenyl]ethynyl}deoxyribose 
• 1332828-78-0 bis-(O-toluoyl)-1β-{[2-(N-trifluoroacyl)-5-(carboxymethyl)phenyl]ethynyl}deoxyribose 
• 1332828-86-0 bis-(O-toluoyl)-1β-[1H-5(carboxymethyl)indol-2-yl]deoxyribose 
• 1332828-82-6 bis-(O-toluoyl)-1α-[1H-5(carboxymethyl)indol-2-yl]deoxyribose 
• 192997-32-3 1-benzyl-1H-indole-5-carboxylic acid methyl ester 
• 190071-25-1 2-phenyl-1H-indole-5-carboxylic acid methyl ester 
• 1154061-16-1 methyl 2-benzyl-1H-indole-5-carboxylate 
• 848485-45-0 methyl 2-(4-methoxyphenyl)-1H-indole-5-carboxylate 

Relevant articles and documents

SPIROCYCLE COMPOUNDS AND METHODS OF MAKING AND USING SAME

Provided herein are compounds and compositions useful as modulators of MAGL. Furthermore, the subject compounds and compositions are useful for the treatment of pain.

BICYCLIC HYDROXAMIC ACIDS USEFUL AS INHIBITORS OF MAMMALIAN HISTONE DEACETYLASE ACTIVITY

A compound of formula (Ia) or (Ib) or a pharmaceutically acceptable salt thereof. The compound is an inhibitor of a histone deacetylase, and as such is useful in terepy, e.g. in the treatment of autoimmune disorders, mental disorders, neurodegenerative disorders, and hyperproliferative disorders.

BIS-(SULFONYLAMINO) DERIVATIVES IN THERAPY 066

The invention provides compounds of formula wherein R1, R3, L1, L2, G1, G2, A and m are as defined in the specification and optical isomers, racemates and tautomers thereof, and pharmaceutically acceptable salts thereof; together with processes for their preparation, pharmaceutical compositions containing them and their use in therapy. The compounds are inhibitors of microsomal prostaglandin E synthase-1.